Survival benefits of metformin in non-diabetics: faulty analysis in a 2014 study
Science Media Centre - 08-Aug-2014It's not logical to advise people without diabetes to take metformin
Join the club for FREE to access the whole archive and other member benefits.
Professor of Pharmacoepidemiology at Cardiff University and director at Pharmatelligence
Experienced consultant in all aspects of medicines evaluation: epidemiology, economics, stats, database analysis and reimbursement strategy.
Specialties: Drug evaluation, device evaluation, drug reimbursement, epidemiology, health economics, medical statistics, clinical trial design, health services research, consultancy, business devotement, large database analysis (GPRD, THIN HES, clinical trials data).
Diseases of particular interest: cardiovascular disease, diabetes, inflammatory disease, dermatological diseases.
See also: Cardiff University - Public Research university.
Details last updated 30-May-2020
It's not logical to advise people without diabetes to take metformin